Plain-English translation of NCT06434597 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , a new medication designed to treat advanced biliary tract cancer (cancer of the bile ducts) or colorectal cancer (colon cancer) in patients whose tumors have specific HER2 genetic changes. Researchers want to see if this medication can slow or shrink these cancers and understand how safe it is. About 60 patients will participate in this study.
Many patients with advanced bile duct or colon cancer have tumors with HER2 changes, but treatment options are limited. This trial is testing whether this medication could offer a new, more effective way to treat these hard-to-treat cancers.
You likely qualify if…
You likely don't qualify if…
You would take tablets regularly as instructed by the research team. The study will monitor how well the medication works against your cancer and track any side effects through regular check-ins, blood tests, and imaging scans. The study team will watch your health closely throughout your participation to make sure the treatment is safe and effective for you.
AI-generated summary from trial data · Aug 29, 2026 · Not medical advice
China